focus -WSS

focus

author：leisure time 2025-10-02 19:15:44 - browse：238

Janet Woodcock -- health policy coverage from STAT — Janet Woodcock, the FDA's principal deputy commissioner Chip Somodevilla/Getty Images

WASHINGTON — It’s the end of an era for the Food and Drug Administration’s longtime drug chief, but she’s drawn the battle plans for the agency’s next chapter.

Janet Woodcock joined the FDA’s biologics division in 1986 but soon moved to the drug side, where over nearly three decades, she oversaw hundreds of reviews, new and evolving classes of therapies and several clashes with Congress and patient advocates. In recent years, she also warded off attacks on the agency’s decisionmaking during the Covid-19 pandemic, particularly when the agency veteran took the acting commissioner role during President Biden’s long search for a permanent leader, and took charge of a vast reorganization plan sparked by the baby formula crisis.

Some of those efforts still hang in the balance as she departs this week. Critics argue that under her oversight, the drug division worked too closely with pharmaceutical companies to give broad approvals to new medicines like Biogen’s Aduhelm or so-called accelerated approval to controversial therapies like Sarepta’s Duchenne muscular dystrophy medicine Exondys 51, which is still in the midst of post-marketing studies to prove its effectiveness.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： FDA's Pazdur wants cancer trials to range beyond China alone

hotspot

focus

WSS

Innovation in antibiotics is ailing. 'Brain drain' may kill it

Ionis drug prevents swelling attacks due to hereditary angioedema

Readout Newsletter: Geron, Novo Nordisk, WuXi updates

Readout Newsletter: Geron, Novo Nordisk, WuXi updates

Future doctors should be trained to promote social change

SCOTUS questions limit to govt efforts to fight misinformation

entertainment

focus

entertainment

DIEP, the 'gold standard' of breast reconstruction, is under threat

For one rare type of lung cancer, Pfizer pill reduces progression by 81%

Medical records are filled with copy

Future doctors should be trained to promote social change

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Woman returns to dialysis after doctors remove transplanted pig kidney

How one medical school became remarkably diverse

Change Healthcare can notify patients about the breach, HHS says

Virginia high school admissions case could be legal follow

Change Healthcare can notify patients about the breach, HHS says

entertainment

Colonoscopy prep: Liquid

Virtual Event: March of the Biosimilars

ASCO Daily Recap: Safety data from Novartis, survival from Pfizer

Creating egg and sperm cells from stem cells raises ethical issues

Kaiser's Risant Health gobbled up Geisinger. Who is next?

Virtual Event: March of the Biosimilars

entertainment

hotspot

focus

hotspot